The ATM facility represents ongoing dilution risk for a micro-cap stock with a $3M market cap. The company has already sold $1.85M in shares this period and can sell another $543K. Monitor for actual sales via daily volume and subsequent 8-K filings. The stock's low price ($3.07) and small float make it susceptible to further downward pressure from ATM sales.
Price Chart
Executive Summary
Aethlon Medical filed an 8-K and a 424B5 prospectus supplement to update the amount of common stock it may sell under its existing ATM agreement with H.C. Wainwright. Following the amendment, the company may offer up to $542,716 in additional shares, on top of $1,849,457 already sold. The filing is a routine administrative update to comply with Form S-3's public float limitations.
Key Facts
- Aethlon filed Amendment No. 1 to its ATM prospectus supplement on June 4, 2026.
- The company may now offer up to $542,716 in common stock under the ATM agreement.
- Previously, $1,849,457 in shares had already been sold under the same prospectus supplement.
- As of June 1, 2026, Aethlon had 2,344,886 shares outstanding, with a public float of 2,337,629 shares.
- The aggregate market value of the public float was $7,176,521 as of May 27, 2026, based on a $3.07 share price.
- The offering is limited by General Instruction I.B.6 of Form S-3 to one-third of public float in any 12-month period.
- The company's market cap is approximately $3 million, and analyst consensus is 0% bullish.
Financial Impact
Up to $542,716 in additional common stock may be sold via ATM, representing ~18% of current market cap. Combined with $1,849,457 already sold, total potential ATM sales in the current 12-month period are $2,392,173.
Risk Factors
- Continued dilution from ATM sales could pressure the stock price.
- The company's small market cap ($3M) and low public float make it vulnerable to selling pressure.
- Analyst consensus is heavily bearish (0% bullish), indicating limited institutional support.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (AEMD) — Batch item 1 | 0001683168-26-004540 |
| Document: aethlon_ex0501.htm | 0001683168-26-004539 |
| Document: 0001683168-26-004540-index-headers.html | 0001683168-26-004540 |
| Document: 0001683168-26-004540-index.html | 0001683168-26-004540 |
| Document: 0001683168-26-004540.txt | 0001683168-26-004540 |
| 424B5 Filing (AEMD) — Batch item 6 | 0001683168-26-004539 |
| Document: 0001683168-26-004539-index-headers.html | 0001683168-26-004540 |
| Document: 0001683168-26-004539-index.html | 0001683168-26-004540 |
| Document: 0001683168-26-004539.txt | 0001683168-26-004540 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | SC 13G | $5.05 $5.07 | ▲ +0.40% | ▼ −0.06% | $5.15 (+1.98%) |
Oct 1, 2026 24d ago | 8-K | $6.45 $6.05 | ▲ +6.20% | ▲ +7.36% | $5.15 (+20.16%) |
Sep 17, 2026 5w ago | 425 | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.15 (−24.04%) |
Sep 17, 2026 5w ago | 8-K | $6.78 $6.77 | ▼ −0.15% | ▼ −0.75% | $5.15 (−24.04%) |
Sep 15, 2026 5w ago | 8-K | $1.47 $6.31 | ▲ +329.25% | ▲ +328.43% | $5.15 (+250.34%) |
Sep 4, 2026 7w ago | DEFA14A | $1.81 $1.47 | ▲ +18.78% | ▲ +17.67% | $5.15 (−184.53%) |
Aug 31, 2026 8w ago | 8-K | $2.06 $1.81 | ▼ −12.14% | ▼ −11.99% | $5.15 (+150.00%) |
Aug 13, 2026 10w ago | Press Release | $2.83 $2.73 | ▼ −3.53% | ▼ −2.17% | $5.15 (+81.98%) |
Jul 31, 2026 12w ago | 8-K | $0.6628 $0.6300 | ▲ +4.95% | ▲ +8.46% | $5.15 (−677.01%) |
Jul 7, 2026 15w ago | EFFECT | $0.7297 $0.6850 | ▲ +6.13% | ▲ +6.68% | $5.15 (−605.77%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers